S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

NCT00088972 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

NETWORK

Sponsor class

Stopped Study closed due to poor accrual.

Conditions

Breast Cancer

Interventions

DRUG: celecoxib
OTHER: placebo

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]